Status:
NOT_YET_RECRUITING
TAMBE Japan Post-Marketing Surveillance
Lead Sponsor:
W.L.Gore & Associates
Collaborating Sponsors:
CMIC Co, Ltd. Japan
Conditions:
Thoracoabdominal Aortic Aneurysm
Pararenal Aortic Aneurysm
Eligibility:
All Genders
Brief Summary
To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Eligibility Criteria
Inclusion
- Patients who were attempted to implant the AC
- Thoracoabdominal aortic aneurysm
- Pararenal abdominal aortic aneurysm
Exclusion
- N/A
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2034
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07147569
Start Date
December 1 2025
End Date
February 28 2034
Last Update
August 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.